Pulsatile secretion pattern of growth hormone in dogs with pituitary-dependent hyperadrenocorticism

Domestic Animal Endocrinology

Volumn 24, Issue 1, 2003, Pages 59-68

  Lee, W M ^a   Meij, B P ^a   Bhatti, S F M ^b   Mol, J A ^a   Rijnberk, A ^a   Kooistra, H S ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Cushing's syndrome; Dog; Glucocorticoids; Growth hormone; Hyperadrenocorticism; Pituitary dependent hyperadrenocorticism (PDH); Pulsatile secretion

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CREATININE; GROWTH HORMONE;

ADRENAL CORTEX HYPERFUNCTION; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DOG; DOG DISEASE; FEMALE; HYPOPHYSIS; MALE; PATHOPHYSIOLOGY; PERIODICITY; SECRETION; URINE;

ADRENAL CORTEX HORMONES; ADRENOCORTICAL HYPERFUNCTION; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CREATININE; DOG DISEASES; DOGS; FEMALE; GROWTH HORMONE; MALE; PERIODICITY; PITUITARY GLAND;

CANIS FAMILIARIS;

EID: 0037224557     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0739-7240(02)00205-9     Document Type: Article

References (64)

1. Takahashi Y, Ebihara S, Nakamura Y, Takahashi K. A model of human sleep-related growth hormone secretion in dogs: effects of 3,6, and 12 hours of forced wakefulness on plasma growth hormone, cortisol, and sleep stages. Endocrinology 1981;109:262-72.
2. Kooistra HS, Den Hertog E, Okkens AC, Mol JA, Rijnberk A. Pulsatile secretion pattern of growth hormone during the luteal phase and mid-anoestrus in beagle bitches. J Reprod Fertil 2000;119:217-22.
3. Lee WM, Diaz-Espineira M, Mol JA, Rijnberk A, Kooistra HS. Primary hypothyroidism in dogs is associated with elevated GH release. J Endocrinol 2001;168:59-66.
4. Plotsky PM, Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science 1985;230:461-3.
5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60.
6. Devesa J, Lima L, Tresguerres JAF. Neuroendocrine control of growth hormone secretion in humans. Trends Endocrinol Metab 1992;3:175-83.
7. Evans RM, Birnberg NC, Rosenfeld MG. Glucocorticoid and thyroid hormones transcriptionally regulate growth hormone gene expression. Proc Natl Acad Sci USA 1982;79:7659-63.
8. Karin M, Castrillo JL, Theill LE. Growth hormone gene regulation: a paradigm for cell-type-specific gene activation. Trends Genet 1990;6:92-6.
9. Seifert H, Perrin M, Rivier J, Vale W. Growth hormone-releasing factor binding sites in rat anterior pituitary membrane homogenates: glucocorticoid. Endocrinology 1985;117:424-6.
10. Miller L, Mayo KE. Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. Endocrinology 1997;138:2458-65.
11. Ohyama T, Sato M, Ohye H, Murao K, Niimi M, Takahara J. Effects of adrenalectomy and glucocorticoid receptor antagonist, RU38486, on pituitary growth hormone-releasing hormone receptor gene expression in rats. Peptides 1998;19:1063-7.
12. Wehrenberg WB, Baird A, Ling N. Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo. Science 1983;221:556-8.
13. Casanueva FF, Burguera B, Muruais C, Dieguez C. Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab 1990;70:234-7.
14. Veldhuis JD, Lizarralde G, Iranmanesh A. Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men. J Clin Endocrinol Metab 1992;74:96-102.
15. Allen DB. Growth suppression by glucocorticoid therapy. Endocrinol Metab Clin North Am 1996;25:699-717.
16. Giustina A, Romanelli G, Bossoni S, Girelli A, Pizzocolo G, Valentini U, et al. Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing hormone in man. Horm Metab Res 1989;21:693-4.
17. Takahashi H, Bando H, Zhang C, Yamasaki R, Saito S. Mechanism of impaired growth hormone secretion in patients with Cushing's disease. Acta Endocrinol 1992;127:13-7.
18. Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. J Clin Endocrinol Metab 1994;78:131-7.
19. Borges MH, DiNinno FB, Lengyel AM. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism. Clin Endocrinol 1997;46:713-8.
20. Kemppainen RJ, Peterson ME. Animal models of Cushing's disease. Trends Endocrinol Metab 1994;5:21-8.
21. Peterson ME, Altszuler N. Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment. Am J Vet Res 1981;42:1881-3.
22. Regnier A, Garnier F. Growth hormone responses to growth hormone-releasing hormone and clonidine in dogs with Cushing's syndrome. Res Vet Sci 1995;58:169-73.
23. Meij BP, Mol JA, Bevers MM, Rijnberk A. Alterations in anterior pituitary function of dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol 1997;154:505-12.
24. Rijnberk A, Van Wees A, Mol JA. Assessment of two tests for the diagnosis of canine hyperadrenocorticism. Vet Rec 1988;122:178-80.
25. Voorhout G, Rijnberk A, Sjollema BE, Van de Ingh TSGAM. Nephrotomography and ultrasonography for the localization of hyperfunctioning adrenocortical tumors in dogs. Am J Vet Res 1990;51:1280-5.
26. Kooistra HS, Voorhout G, Mol JA, Rijnberk A. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol 1997;152:387-94.
27. Meij BP, Voorhout G, Van Den Ingh TSGAM, Hazewinkel HAW, Teske E, Rijnberk A. Results of transsphenoidal hypophysectomy in 52 dogs with pituitary-dependent hyperadrenocorticism. Vet Surg 1998;27:246-61.
28. Findling JW, England WC. A new immunoradiometric assay for the measurement of corticotropin in human plasma. Trends Endocrinol Metab 1990;6:678.
29. Stolp R, Rijnberk A, Meijer JC, Croughs RJ. Urinary corticoids in the diagnosis of canine hyperadrenocorticism. Res Vet Sci 1983:34:141-4.
30. Eigenmann JE, Eigenmann RY. Radioimmunoassay of canine growth hormone. Acta Endocrinol 1981;98:628-34.
31. Merriam GR, Wachter KW. Algorithms for the study of episodic hormone secretion. Am J Physiol 1982;243:310-8.
32. Wajchenberg BL, Liberman B, Gianella Neto D, Morozimato MY, Semer M, Bracco LO, et al. Growth hormone axis in Cushing's syndrome. Horm Res 1996;45:99-107.
33. Ohyama T, Sato M, Niimi M, Hizuka N, Takahara J. Effects of short- and long-term dexamethasone treatment on growth and growth hormone (GH)-releasing hormone (GRH)-insulin-like growth factor-1 axis in conscious rats. Endocrine 1997;44:827-35.
34. Wehrenberg WB, Bergman PJ, Stagg L, Ndon J, Giustina A. Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies. Endocrinology 1990;127:2705-8.
35. Lima L, Arce V, Diaz MJ, Tresguerres JA, Devesa J. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons. J Clin Endocrinol Metab 1993;76:439-44.
36. Terzolo M, Bossoni S, Ali A, Doga M, Reimonda G, Milani G, et al. Growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone. J Clin Endocriol Metab 2000;85:1310-5.
37. Nakagawa K, Ishizuka T, Obara T, Matsubara M, Akikawa K. Dichotomic action of glucocorticoids on growth hormone secretion. Acta Endocrinol 1987;116:165-71.
38. Nakagawa K, Ishizuka T, Shimizu C, Ito Y, Wakabayashi I. Increased hypothalamic somatostatin mRNA following dexamethasone administration in rats. Acta Endocrinol 1992;127:416-9.
39. Mallo F, Alvarez CV, Benitez L, Burguera B, Coya R, Casanueva FF, et al. Regulation of His-dTrp-Ala-Trp-dPhe-Lys-NH2 (GHRP-6)-induced GH secretion in the rat. Neuroendocrinology 1993;57:247-56.
40. Leal-Cerro A, Pereira JL, Garcia-Luna PP, Astorga R, Cordido F, Casanueva FF, et al. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on growth hormone (GH) responses to GH-releasing hormone in patients with Cushing's syndrome. Clin Endocrinol 1990;33:291-5.
41. Miell J, Corder R, Miell PJ, McClean C, Galliard RC. Effects of glucocorticoid treatment and acute passive immunization with growth hormone-releasing hormone and somatostatin antibodies on endogenous and stimulated growth hormone secretion in the male rat. J Endocrinol 1991;131:75-86.
42. Senaris RM, Lago F, Coya R, Pineda J, Dieguez C. Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids. Endocrinology 1996;137:5236-41.
43. Hotta M, Shibasaki T, Masuda A, Imaki T, Sugino N, Demura H, et al. Effect of human growth hormone-releasing hormone on GH secretion in Cushing's syndrome and non-endocrine disease patients treated with glucocorticoids. Life Sci 1988;42:979-84.
44. Burguera B, Muruais C, Penalva A, Dieguez C, Casanueva FF. Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man. Neuroendocrinology 1990;51:51-8.
45. Voltz DM, Piering AW, Magestro M, Giustina A, Wehrenberg WB. Effect of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment. Life Sci 1995;56:491-7.
46. Watson S, Porter RJ, Young AH. Effect of hydrocortisone on the pituitary response to growth hormone releasing hormone. Psychopharmacology 2000;152:40-6.
47. Leal-Cerro A, Pumar A, Garcia-Garcia E, Dieguez C, Casanueva FF. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Clin Endocrinol 1994;41:649-54.
48. Miki N, Ono M, Murata Y, Ohsaki E, Tamitsu K, Yamada M, et al. Regulation of pituitary growth hormone-releasing factor (GRF) receptor gene expression by GRF. Biochem Biophys Res Commun 1996;224:586-90.
49. Thakore JH, Dinan TG. Growth hormone secretion: the role of glucocorticoids. Life Sci 1994;55:1083-99.
50. Leal-Cerro A, Pumar A, Villamil F, Astorga R, Dieguez C, Casanueva FF. Growth hormone releasing hormone priming increases growth hormone secretion in patients with Cushing's syndrome. Clin Endocrinol 1993;38:399-403.
51. Niimi K, Krieg Jr RJ, Hanna JD, Santos F, Chan JC. Glucocorticoid-induced changes in the quantity and secretory capacity of individual rat somatotropes. J Am Soc Nephrol 1993;3:1428-33.
52. Rijnberk A. Hypothalamus-pituitary system. Clinical endocrinology of dogs and cats. Kluwer Academic Publishers: Dordrecht, The Netherlands; 1996.
53. Cordido F, Penalva A, Dieguez C, Casanueva FF. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 1993;76:819-23.
54. Leal-Cerro A, Jimenez LM, Astorga R, Fernandez-Lopez I, Dieguez C, Casanueva FF. Acute pharmacological reduction of plasma free fatty acids enhances the growth hormone (GH)-releasing hormone-mediated GH secretion in patients with Cushing's syndrome. J Clin Endocrinol Metab 1997;82:3165-8.
55. Pombo M, Pombo CM, Astorga R, Cordido F, Popovic V, Garcia-Mayor RV, et al. Regulation of growth hormone secretion by signals produced by the adipose tissue. J Endocrinol Invest 1999;22:22-6.
56. Leal-Cerro A, Venegas E, Garcia-Pesquera F, Jimenez LM, Astorga R, Casanueva FF, et al. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome. Clin Endocrinol 1998;48:117-21.
57. Finkelstein JW, Roffwarg HP, Bouar RM, Kream HJ, Hellman L. Age-related change in the twenty-four-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 1972;35:665-70.
58. Zadik Z, Chalew SA, McCarter Jr RJ, Meistas M, Kowarski AA. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 1985;60:513-6.
59. Wilshire GB, Loughlin JS, Brown JR, Adel TE, Santoro N. Diminished function of the somatotropic axis in older reproductive-aged women. J Clin Endocrinol Metab 1995;80:608-13.
60. Sonntag WE, Steger RW, Forman LJ, Meites J. Decreased pulsatile release of growth hormone in old male rats. Endocrinology 1980;107:1875-9.
61. De Gennaro Colonna V, Cella SG, Parenti M, Locatelli V, Cocchi D, Muller EE. Neuroendocrine aging: its impact on somatotrophic function. Neurochem Int 1994;25:5-10.
62. Shetty KP, Duthie EH. Anterior pituitary function and growth hormone use in the elderly. Endocrinol Metab Clin North Am 1995;24:213-31.
63. Veldhuis JD. Altered pulsatile and coordinate secretion of pituitary hormones in aging: evidence of feedback disruption. Aging 1997;9(Suppl 4):19-20.
64. Takahashi S, Kawashima S, Seo H, Matsui N. Age-related changes in growth hormone and prolactin messenger RNA levels in the rat. Endocrinol Jpn 1990;37:827-40.